Methods and compositions for inhibiting virus
US-2025382618-A1 · Dec 18, 2025 · US
This page is not indexed by search engines while we improve data quality.
Smith David Bernard patents
Smith David Bernard is listed as an inventor on 77 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Smith David Bernard |
| Total patents | 77 |
| First publication | Feb 5, 2015 |
| Latest publication | Dec 18, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Substituted nucleosides, nucleotides and analogs thereof
US-12173025-B2 · Dec 24, 2024 · US
Bicyclic compounds
US-2024150351-A1 · May 9, 2024 · US
Pyrrole compounds
US-2023390242-A1 · Dec 7, 2023 · US
Pyrrole compounds
US-11771680-B2 · Oct 3, 2023 · US
Substituted nucleosides, nucleotides and analogs thereof
US-2023167151-A1 · Jun 1, 2023 · US
Substituted nucleosides, nucleotides and analogs thereof
US-11590155-B2 · Feb 28, 2023 · US
SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF FOR CORONAVIRUS DISEASES
US-2022380770-A1 · Dec 1, 2022 · US
Substituted nucleosides, nucleotides and analogs thereof
US-11485753-B2 · Nov 1, 2022 · US
Modified gapmer oligonucleotides and methods of use
US-11466274-B2 · Oct 11, 2022 · US
Recent patents
Latest publications not already listed above.
Conjugates of s-antigen transport inhibiting oligonucleotide polymers having enhanced liver targeting
US-2022160748-A1 · May 26, 2022 · US
S-antigen transport inhibiting oligonucleotide polymers and methods
US-2022125825-A1 · Apr 28, 2022 · US
Pyrrole compounds
US-2022071957-A1 · Mar 10, 2022 · US
Pyrrole compounds
US-11191747-B2 · Dec 7, 2021 · US
S-antigen transport inhibiting oligonucleotide polymers and methods
US-11166976-B2 · Nov 9, 2021 · US
Antisense oligonucleotide (aso) molecules and uses thereof for coronavirus diseases
US-2021317457-A1 · Oct 14, 2021 · US
S-antigen transport inhibiting oligonucleotide polymers and methods
US-2021189392-A1 · Jun 24, 2021 · US
Bicyclic sulfonamides
US-11033556-B2 · Jun 15, 2021 · US
S-antigen transport inhibiting oligonucleotide polymers and methods
US-2020405743-A1 · Dec 31, 2020 · US
Modified gapmer oligonucleotides and methods of use
US-2020385735-A1 · Dec 10, 2020 · US
Bicyclic sulfonamides
US-2020345749-A1 · Nov 5, 2020 · US
Pyrrole compounds
US-2020323821-A1 · Oct 15, 2020 · US
S-antigen transport inhibiting oligonucleotide polymers and methods
US-2020147124-A1 · May 14, 2020 · US
Substituted nucleosides, nucleotides and analogs thereof
US-10485815-B2 · Nov 26, 2019 · US
Substituted nucleosides, nucleotides and analogs thereof
US-10464965-B2 · Nov 5, 2019 · US
Aza-pyridone compounds and uses thereof
US-2019314373-A1 · Oct 17, 2019 · US
Substituted nucleosides, nucleotides and analogs thereof
US-10370401-B2 · Aug 6, 2019 · US
Substituted nucleosides, nucleotides and analogs thereof
US-10307439-B2 · Jun 4, 2019 · US
Aza-pyridone compounds and uses thereof
US-10251882-B2 · Apr 9, 2019 · US
Substituted nucleosides, nucleotides and analogs thereof
US-2019085011-A1 · Mar 21, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Alios Biopharma Inc | 54 |
| Aligos Therapeutics Inc | 19 |
| Univ Emory | 3 |
| Janssen Pharmaceutica Nv | 3 |
| Vertex Pharma | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P31/14 | 61 |
| A61K31/7076 | 41 |
| C07H19/10 | 37 |
| C07H19/20 | 36 |
| C07H19/06 | 35 |